¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reverse cholesterol transport"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reverse mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • reverse osmosis
    ¿ª»ïÅõ
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
  • reverse primer
    µÞ±æÀâÀÌ
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò
  • reverse transcriptase polymerase chain reaction
    ¿ªÀü»çÈ¿¼ÒÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • reverse transcription
    ¿ªÀü»ç
  • reverse Waters position
    ¿ª¿öÅͽºÀÚ¼¼
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • transport defect
    ¿î¹Ý°áÇÔ
  • facilitated transport
    ÃËÁø¿î¹Ý
  • transport host
    ¿î¹Ý¼÷ÁÖ
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
  • maximum tubular transport
    ÃÖ°í¿ä¼¼°üÀ̵¿Ä¡
  • membrane transport
    ¸·¿î¹Ý
  • transport medium
    ¿î¹Ý¹èÁö
  • net transport
    ¼ø¿î¹Ý
  • transport number
    À̵¿ºÐÀ²
  • passive transport
    ¼öµ¿¿î¹Ý
  • supersonic transport
    ÃÊÀ½ÆÄ¼ö¼Û
  • transport
    ¿î¹Ý
  • transcapillary transport
    ¸ð¼¼°ü¿î¹Ý
  • transmembrane transport
    ¸·¿î¹Ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reverse action clasp
    ¿ªÀÛ¿ë°¥°í¸®.
  • reverse anaphylaxis
    ¿ª¾Æ³ªÇʶô½Ã(潡­)
  • reverse comma sign
    ¿ªÄÞ¸¶Â¡ÈÄ, ¿ª½°Ç¥Â¡ÈÄ(¡­ó£ý¦).
  • reverse comma sign
    ¿ªÄÞ¸¶Â¡ÈÄ(潡­ó£ý¦), ¿ª½°Ç¥Â¡ÈÄ(潡­øúó£ý¦)
  • reverse mutation =back m.
    º¹±Í(µ¹¿¬)º¯ÀÌ(ÜÖÏýÔÍæÔܨì¶).
  • reverse mutation =back m.
    º¹±Í(µ¹¿¬)º¯ÀÌ(ÜÖÏýÔÍæÔܨì¶).
  • reverse mutation =back m.
    º¹±Í(µ¹¿¬)º¯ÀÌ(ÜÖÏýÔÍæÔܨì¶).
  • reverse osmosis
    ¿ª»ïÅõ(æ½ß¶÷â).
  • reverse passive anaphylaxis
    ¿ª¼öµ¿(æ½áôÔÑ)¾Æ³ªÇʶô½Ã½º.
  • reverse passive hemagglutination=RPHA
    ¿ª¼öµ¿Ç÷±¸ÀÀÁý¹ý
  • reverse phase liquid chromatography
    ¿ª»ó¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • reverse piezoelectric effect
    ¿ª ¾ÐÀüÈ¿°ú
  • reverse transcriptase
    ¿ªÀü»ç È¿¼Ò
  • reverse transcriptase
    ¿ªÀüÆ®·£½ºÅ©¸³Å×ÀÌÁî
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • active transport
    ´Éµ¿¼ö¼Û (ÒöÔÑâÃáê)
  • anion-transport protein
    À½À̿¿î¹Ý(ê¡Úõ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • binding protein transport system
    °áÇÕ ´Ü¹éÁú ¼ö¼Û(Ì¿ùêÓ±ÛÜòõâÃáê) ½Ã½ºÅÛ
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¼ö¼Û(ì£ß«ûù÷©áÈâÃáê)
  • cotranslational transport
    ¹ø¿ªµ¿½Ã¼ö¼Û(Ûèæ»ÔÒãÁâÃáê)
  • coupled transport
    "°ø¿ª¼ö¼Û(ÍëæµâÃáê), ¦Áø¼ö¼Û"
  • electron transport chain
    ÀüÀÚ¼ö¼Û(ï³í­âÃáê) »ç½½
  • electron transport particle
    ÀüÀÚ¼ö¼Û ÀÔÀÚ(ï³í­âÃáêØ£í­)
  • electron transport system
    ÀüÀÚ¼ö¼Û(ï³í­âÃáê) ½Ã½ºÅÛ
  • fractional electrical transport
    ºÐº° Àü±â ¼ö¼Û(ÝÂܬï³Ñ¨âÃáê)
  • gradient-coupled active transport
    ±¸¹è(ÎþÛÕ) ¦Áø ´Éµ¿¼ö¼Û(ÒöÔÑâÃáê)
  • homocellular transport
    µ¿Áú¼¼Æ÷ ¼ö¼Û(ÔÒòõá¬øàâÃáê)
  • hydrogen transport system
    ¼ö¼Ò ¼ö¼Û(â©áÈâÃáê) ½Ã½ºÅÛ
  • illicit transport
    ¹Ð¼ö¼Û(ÚËâÃáê)
  • intracellular transport
    ¼¼Æ÷³» ¼ö¼Û(á¬øàÒ®âÃáê)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
rev reverse; review; revolution
RO radiation oncology; radiation output; ratio of; relative odds; renal osteodystrophy; reverse osmosis...
RP radial pulse; radiopharmaceutical; rapid processing [of film]; Raynaud phenomenon; reactive protein;...
RPA radial photon apsorptiometry; replication protein A; resultant physiologic acceleration; reverse pas...
RP-HPLC reverse phase-high performance liquid chromatography
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ETC Electron transport chain
FATP Fatty acid transport protein
HAChT High affinity choline transport
IFT Intraflagellar transport
MCT Mucociliary transport
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¿î¹Ý
  • carrier mediated transport
    ¿î¹Ýü ¸Å°³ À̵¿
  • co-transport
    °øµ¿ ¿î¹Ý, °øµ¿ À̵¿, °øµ¿ ¼ö¼Û)
  • downhill transport
    Çǵ¿ ¿î¹Ý
  • oxygen transport mechanism
    »ê¼Ò ¿î¹Ý ±âÀü
  • passive transport
    Çǵ¿Àû ¿î¹Ý, Çǵ¿Àû À̵¿, ¼öµ¿Àû À̵¿
  • sodium transport system
    ³ªÆ®·ý ¿î¹Ý°è
  • transport
    ¼ö¼Û, ¿î¼Û
    »ý¹°°è¿¡ ÀÖ´Â ¹°ÁúÀÇ À̵¿À¸·Î¼­, ƯÈ÷ ¼¼Æ÷ÀÇ ³»¿Ü³ª »óÇÇÃþÀ» ÅëÇØ¼­ À̵¿ÇÏ´Â °Í.
  • transport oxygen
    »ê¼Ò ¿î¹Ý
  • virus transport medium
    ¹ÙÀÌ·¯½º ¿î¼Û ¹èÁö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
reverse transcriptase PCR A technique used to amplify RNA targets. The specimen containing the target RNA (e.g., HIV-1 RNA, Hepatitis C Virus RNA) is subjected to reverse transcription to make complementary DNA (cDNA), which is then, in turn, amplified by PCR.
Acronym: RT-PCR
(05 Mar 2000)
reverse transcription <molecular biology> The process of copying information found in RNA into DNA.
(09 Oct 1997)
reverse transcriptons An enzyme that converts RNA to DNA. Some viruses have only RNA as their primary genetic material. By converting their RNA genes to DNA with this enzyme, the host cell is 'tricked' into creating new copies of the virus. Useful in genetic engineering to make DNA from mRNA.
(14 Nov 1997)
reverse Trendelenburg position Supine position without flexing or extending, in which the head is higher than the feet.
(05 Mar 2000)
HIV-1 reverse transcriptase <enzyme> HIV-1 enzyme responsible for the synthesis of DNA from genomic RNA of the virus. It is encoded by the pol gene of HIV-1.
Registry number: EC 2.7.7.-
(12 Dec 1998)
HIV-2 reverse transcriptase <enzyme> Responsible for synthesis of double-stranded DNA from the genomic RNA of the virus; has rnase h and DNA-dependent DNA polymerase activities; was indexed as reverse transcriptase (87-91)
Registry number: EC 2.7.7.-
(26 Jun 1999)
DNA reverse gyrase <enzyme> A topoisomerase II subclass which introduces positive superhelical turns into DNA
Registry number: EC 3.1.-
Synonym: reverse gyrase
(26 Jun 1999)
triiodothyronine, reverse <chemical> 0-(4-hydroxy-3,5-diiodophenyl)-3-iodo-l-tyrosine. A metabolite of thyroxine formed by the peripheral degradation of thyroxine as a result of the tyrosyl or inner ring 5-deiodination. In systemic disease states or in neonates, levels of triiodothyronine are low and those of reverse triiodothyronine are elevated. Reverse t3 is therefore useful as a diagnostic aid and in the treatment of foetal and infantile hypothyroidism.
Chemical name: L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3-iodo-
(12 Dec 1998)
acid cholesterol ester synthetase <enzyme> Aortal enzyme, does not require exogenous ATP or CoA; reverse reaction of cholesterol esterase
Registry number: EC 3.1.1.-
Synonym: cholesterol ester synthetase
(26 Jun 1999)
good cholesterol High-density lipoprotein (HDL) cholesterol.
(12 Dec 1998)
cholesterol 1. <biochemistry> A pearly, fatlike steroid alcohol, C27H45OH, crystallizing in the form of leaflets or plates from dilute alcohol and found in animal fats and oils, in bile, blood, brain tissue, milk, yolk of egg, myelin sheaths of nerve fibres, the liver, kidneys and adrenal glands.
It constitutes a large part of the most frequently occurring type of gallstones and occurs in atheroma of the arteries, in various cysts and in carcinomatous tissue. Most of the bodys cholesterol is synthesised in the liver, but some is absorbed from the diet. It is a precursor of bile acids and is important in the synthesis of steroid hormones.
2. <chemical> A commercial preparation of cholesterol is used as a pharmaceutic aid.
Synonym: cholesterin.
Origin: Gr. Stereos = solid
(15 Jan 1998)
cholesterol 26-hydroxylase <enzyme> Cyt p-450 dependent, ferredoxin involved
Registry number: EC 1.14.15.-
(26 Jun 1999)
cholesterol-5 alpha,6 alpha-epoxide hydrase <enzyme> Aspect of epoxide hydrolase, EC 3.3.2.3
Pharmacological action: carcinogen
Registry number: EC 3.3.2.-
Synonym: cholesterol epoxide hydrase, cholesterol epoxide hydrolase
(26 Jun 1999)
cholesterol 7 alpha-monooxygenase <enzyme> An enzyme that catalyses the hydroxylation of cholesterol to cholest-5-en-3 beta,7 alpha-diol.
Chemical name: Cholesterol,NADPH:oxygen oxidoreductase (7 alpha-hydroxylating)
Registry number: EC 1.14.13.17
(12 Dec 1998)
cholesterol, bad Low-density lipoprotein (LDL) cholesterol.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • double reverse
    ´õºí ¸®¹ö½º
  • reverse
    ¿ª;¹Ý´ë;µÚ;¹è¸é;¹èÈÄ;(ÁÖÈ­.¸Þ´ÞµîÀÇ)µÞ¸é;(ÆîÄ£ Ã¥ÀÇ)¿ÞÂÊÆäÀÌÁö;Àüµµ;(ÀÚµ¿Â÷ÀÇ)ÈÄÁø;ÈÄÁø±â¾î;¿ªÀü(¿ªÁø)ÀåÄ¡;¿ªÀü;¿ª(ÁÂ)ȸÀü;°³¸Ó¸®ÆÇ;µÚ³¡(â.ÃѵîÀÇ);ºÒ¿î;½ÇÆÐ;ÆÐ¹è;°Å²Ù·ÎÀÇ;»ó¹ÝµÇ´Â;µÚ(À̸é)ÀÇ;¹èÈÄÀÇ;µÚ·Î ÇâÇÑ;¿ªÀüÇÏ´Â;ÈÄÅð¿ëÀÇ;(À§Ä¡.¹æÇâ.¼ø¼­µîÀ»)°Å²Ù·Î
  • reverse advertising
    ¿ª±¤°í(¼ÒºñÀÚ°¡ ±×ÀÇ ¿ä±¸¸¦ µ¥ÀÌÅͺ£À̽º¿¡ ÀÔ·ÂÇÏ¸é °ø±ÞÀÚ°¡ ±×°ÍÀ» º¸°í °í°´À» ã¾Æ³»´Â ¹æ¹ý)
  • reverse angle
    ¿ª°¢µµ(Ä«¸Þ¶ó À§Ä¡¸¦ ¹Ù²Ù¾î ÁÖ¿ä ÇÇ»çüÀÇ µÚ·Î µ¹¾Æ ´ë¸éÇϰí ÀÖ´Â ¸®Æ÷Å͸¦ ºñÄ¡´Â ¹æ¹ý)
  • reverse commuting
    ¿ª¹æÇâ Åë±Ù(µµ½Ã¿¡¼­ ±³¿Ü·Î)
  • reverse culture shock
    ¿ª¹®È­ ¼îÅ©(¿Ü±¹¿¡¼­ ¿À·§µ¿¾È »ýȰÇÑ »ç¶÷ÀÌ °í±¹À¸·Î µ¹¾Æ¿ÔÀ» ¶§ ´À³¢´Â ¼Ò¿Ü°¨)
  • reverse discrimination
    ¿ªÂ÷º°(ÇÇÂ÷º°ÀÚ ¿ì´ë·Î »ý±â´Â ±×¹ÛÀÇ »ç¶÷ÀÇ ºÒ¸®)
  • reverse engineering
    ºÐÇØ °øÇÐ;¿ª¼³°è(½ÅÁ¦Ç°À» ¼³°èÇÏ¿© ±¸Á¶¸¦ Á¤¹ÐÇÏ°Ô ºÐ¼®.±× ¼³°è¸¦ ¿ªÀ¸·Î ŽÁöÇÏ´Â ±â¼ú)
  • reverse gear
    (ÀÚµ¿Â÷ÀÇ)ÈÄÁø ±â¾î
  • reverse racism
    ¿ªÀÎÁ¾ Â÷º°(ÈæÀÎ.¼Ò¼ö ¹ÎÁ·ÀÇ Â÷º°ÆóÁö ¶§¹®¿¡ ¹éÀÎÀÌ ÀÔÇÐ.Ãë¾÷¿¡¼­ ¿ÀÈ÷·Á ºÒ¸®ÇØ Áö´Â »óÅÂ)
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò(RNA¿¡ ÀÇÁ¸ÇÏ¿© DNA¸¦ ÇÕ¼º½ÃŰ´Â È¿¼Ò)
  • reverse-charge
    (ÅëÈ­¿ä±ÝÀÌ)¼ö½ÅÀÎ ÁöºÒÀÇ
  • reverse-engineered
    ºÐÇØÇÏ¿© ¸ð¹æÇÑ(¹ÝµµÃ¼¿¡ ´ëÇÏ¿© ÈçÈ÷ ¾¸)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á